T1	Participants 579 691	124 children, aged 4 through 13 years, with PDDs, accompanied by frequent tantrums, self-injury, and aggression.
T2	Participants 692 757	The children were randomized 3:2 to COMB (n = 75) or MED (n = 49)
T3	Participants 763 893	participants received risperidone monotherapy from 0.5 to 3.5 mg/day (with switch to aripiprazole if risperidone was ineffective).
T4	Participants 1343 1394	roups did not differ on Clinical Global Impressions
